Release Date: 03/11/20 08:24 Summary: September Quarter 2020 Update Price Sensitive: Yes Download Document 226.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%